PathNet
PathNet is a privately held digital pathology laboratory network providing turnkey digital sign-out, proprietary tissue handling tools, and AI-integrated diagnostics to independent pathology practices and urology, dermatology, and gastroenterology clinics across 27 US states.
- Company typePrivate
- Founded2019
- HeadquartersLittle Rock, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What PathNet does
PathNet is a privately held digital pathology laboratory network founded in 2019 (spun out from Lumea) and headquartered in Little Rock, Arkansas, operating a national footprint across 27 US states. The company provides turnkey digital pathology, laboratory, and business support services primarily to independent pathology practices and specialty clinics in urology, dermatology, and gastroenterology. Its core technical platform combines cloud-based whole-slide imaging for remote digital sign-out via iPad or monitor, the BxLink Laboratory Information System for specimen-to-report workflow, and proprietary pre-analytic tools (BxBoard® tissue collection device and BxChip® clinical tissue array) that preserve tissue orientation and reduce handling overhead for prostate biopsies.
The platform's clinical workflow integrates third-party AI capabilities through strategic partnerships: AIRA Matrix for prostate cancer detection and Gleason grading, Valar Labs for bladder cancer risk stratification and BCG response prediction, AIxMed for AI-powered urine cytology under The Paris System, Tempus Edge Platform for biomarker identification, and Alpenglow Biosciences for 3D volumetric tissue imaging. PathNet reports diagnostic accuracy 20-40% above national averages in certain specialties and 24-48 hour lab-to-report turnaround for prostate biopsies, with full federal CLIA certification and state licensure in California, Maryland, DC, and New York. Its TruCore pathology network operates as an embedded flagship customer and affiliated group.
The business model combines recurring subscription revenue from laboratory diagnostic services and digital pathology platform access with professional services revenue from business support offerings (billing, collections, licensing, marketing). Distribution is via direct enterprise sales to pathology groups and clinics, with no publicly disclosed pricing. The company is founder/management-controlled with no disclosed institutional funding rounds and CEO Jason A. Camilletti (appointed August 2022, succeeded founder Dr. Matthew O. Leavitt who remains Chairman).
PathNet firmographics
Firmographics- Name
- PathNet
- Legal name
- PathNet Inc
- Website
- https://pathnetlab.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- PathNet is a privately held digital pathology laboratory network providing turnkey digital sign-out, proprietary tissue handling tools, and AI-integrated diagnostics to independent pathology practices and urology, dermatology, and gastroenterology clinics across 27 US states.
- Ownership category
- akta.pro rank
PathNet industry classification
Industry- Product category
- Digital Pathology Laboratory Services
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)
- akta.pro secondary industries
- Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI), Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers) (HLAAAMAI), Urology Telemedicine Platforms (HLALAGAN)
Keywords
Where PathNet is headquartered
LocationHeadquarters
- HQ city
- Little Rock
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PathNet business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Laboratory Diagnostic Services: Provides pathology laboratory services including tissue processing, slide preparation, and digital scanning for pathology groups. Specimens are shipped to PathNet laboratories and results returned within 24-48 hours.
- Digital Pathology Platform Access: Software-as-a-service access to digital pathology sign-out platform with AI integration capabilities for quality assurance and remote collaboration.
- Business Support Services: Billing, collections, accounting, licensing, marketing support, and customer support services for independent pathology practices.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
PathNet product offering
Product offeringCore offering
PathNet operates a national digital pathology laboratory network that delivers whole-slide digital imaging, cloud-based remote case sign-out, AI-integrated quality assurance, tissue processing using proprietary BxBoard/BxChip collection devices, and administrative business support services. The company processes specimens shipped from urology, dermatology, and gastroenterology practices and returns diagnostic results within 24-48 hours across 27 US states.
Product overview
PathNet is a digital pathology laboratory network offering a unified platform combining digital pathology sign-out, laboratory diagnostics, and business support services. The core offerings include the Digital Pathology Platform for cloud-based case review and remote sign-out, BxLink Laboratory Information System for workflow management, and specialized tissue collection/processing tools (BxBoard, BxChip). AI capabilities are delivered through strategic partnerships including AIRA Matrix's AI Prostate Suite for computer vision-based prostate cancer detection and grading, Valar Labs' Vesta portfolio for bladder cancer prognostic and predictive analytics, AIxMed's AIxURO for urine cytology analysis, and Alpenglow Biosciences' 3D volumetric imaging for advanced spatial analytics. The company also provides business support services (billing, marketing, licensing) and operates TruCore, a network of affiliated pathology practices. The platform serves urology, dermatology, and gastroenterology specialties across 27 US states.
Differentiator
Problem solved
Functional benefit
Products and services
- Digital Pathology Platform Whole-slide digital imaging and cloud-based pathology platform enabling pathologists to sign out cases remotely on computer monitors or iPad Pro tablets, with automated measurements, AI-assisted report generation, and AI integration for quality assurance. Built for independent pathology groups seeking to modernize microscopy workflows.
- BxLink Laboratory Information System (LIS) Laboratory information system supporting pathology workflow from specimen intake to report generation, integrating electronic patient data with physical specimens, enabling order management, encounter creation, and specimen tracking across urology, dermatology, dermatopathology, and surgical pathology specialties. Integrates with EMR/EHR systems.
- BxBoard Tissue Collection Device Patented tissue collection device that holds six prostate biopsy cores, reducing specimen jars from 12-24 to 2-3 boards per procedure while preserving tissue orientation for accurate diagnosis.
- BxChip Clinical Tissue Array Clinical tissue array made of artificial tissue-like material that receives and holds multiple tissue cores, enabling processing, embedding and sectioning as a single standard tissue while maintaining orientation. Allows up to 18 prostate cores on a single glass slide.
- Laboratory Diagnostic Services National pathology laboratory services including tissue processing, slide preparation, and digital scanning for pathology groups. Specimens are shipped to PathNet's laboratories and digital results returned within 24-48 hours for prostate biopsies.
- Business Support Services Administrative and operational support services for independent pathology practices including billing, collections, bookkeeping, licensing, onboarding, training, marketing, website management, and patient education materials.
- TruCore Pathology Network Network of forward-thinking pathologists leveraging PathNet's digital laboratory solutions, providing virtual collaboration between pathologists, clinicians, and patients with timely diagnostic insights. Operates with its own CLIA certification (04D2299038).
- AI Prostate Suite (AIRA Matrix) AI-powered prostate cancer detection and grading suite providing computer vision analysis of digital pathology slides. Offers second-opinion AI review for cancer detection and Gleason score classification during prostate biopsy diagnosis.
- Vesta Bladder Cancer Diagnostics (Valar Labs) AI-powered diagnostic portfolio for non-muscle invasive bladder cancer (NMIBC) including Vesta Bladder Risk Stratify (prognostic risk stratification) and Vesta Bladder BCGPredict (BCG therapy response prediction). Computational pathology analysis for personalized bladder cancer management.
- AIxURO Urine Cytology (AIxMed) AI-powered urine cytology analysis technology for bladder cancer diagnostics utilizing The Paris System (TPS) for standardized reporting. Designed to improve diagnostic accuracy, workflow efficiency, and reduce invasive cystoscopy procedures.
- 3D AI Cancer Diagnostics (Alpenglow) 3D volumetric tissue imaging and AI-powered spatial analytics for prostate and bladder cancer diagnostics. Includes co-developed 3D AI prostate cancer predictive assay and 3D digital biomarker for bladder carcinoma in situ (CIS).
- Tempus Edge Platform Integration Access to Tempus Edge platform providing AI models for identifying specimens with actionable biomarkers using H&E stained slides. Part of computational pathology capabilities for biomarker identification and therapeutic decision support.
- URO17 Bladder Biomarker Test Bladder cancer biomarker test offered through ancillary and molecular testing pathways for bladder cancer detection and monitoring.
Quantifiable outcome
- 20-40% higher cancer detection rates than national average in certain specialties
- +3 more outcomes
Companies that use PathNet
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
PathNet technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability10 records
Feature6 records
PathNet partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Alpenglow BiosciencescoreStrategic partnership to develop, validate, and commercialize 3D AI-enabled diagnostic tests for prostate and bladder cancer. PathNet will deploy an Alpenglow-ZEISS 3D microscope in its Little Rock laboratory for true volumetric tissue imaging at clinical scale. Co-development includes a 3D AI prostate cancer predictive assay and a 3D digital biomarker for bladder carcinoma in situ (CIS).
- Valar LabscoreStrategic partnership to deliver AI-powered bladder cancer diagnostics nationwide. PathNet's national laboratory network will provide access to Vesta Bladder Risk Stratify and Vesta Bladder BCGPredict for non-muscle invasive bladder cancer management. Combines Valar Labs' computational pathology capabilities with PathNet's laboratory infrastructure.
- AIxMedcoreStrategic partnership to enhance digital pathology services with AIxMed's AIxURO™ technology for AI-powered urine cytology analysis. The integration aims to improve bladder cancer diagnostics and workflow efficiency, supporting clinical decision-making and potentially reducing invasive procedures.
- AIRA MatrixcoreCollaboration to provide AI-powered prostate cancer diagnosis using AIRA Matrix's AI Prostate Suite. The partnership arms PathNet pathologists with cutting-edge AI tools for detecting and grading cancer, providing a second set of digital eyes for improved diagnostic accuracy and Gleason scoring.
- MoticminorCollaboration on Uruguay's first clinical validation study of a fully digital diagnostic platform using Motic's EasyScan Pro 6 whole-slide imaging system. Study involves 50 patients comparing digital sign-out and traditional pathology methods.
- TruCore Pathology GroupcoreTruCore is a group of forward-thinking pathologists leveraging PathNet's digital laboratory solutions. TruCore pathologists virtually work alongside clinical colleagues, providing timely insights and diagnostic intelligence through PathNet's platform.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
PathNet competitors and assessment
Company assessmentDirect peers
- Inform Diagnostics: Inform Diagnostics (formerly Caris MPI / Pathology Inc.) is a national subspecialty pathology lab serving dermatologists, urologists, gastroenterologists, and other specialists. Directly comparable to PathNet on vertical, specialty, and client base of independent clinics sending biopsy specimens.
- PathAI: PathAI builds AI-powered pathology tools for diagnostic and biopharma applications, including prostate and oncology indications. Compares to PathNet on AI pathology focus and biopharma-adjacent datasets, though PathAI skews more toward research/pharma than independent clinical practices.
- Ibex Medical Analytics: Ibex develops AI algorithms for cancer detection and grading across breast, prostate, and other tissues, deployed as a second-reader/QA layer in pathology workflows. Directly comparable to PathNet's AIRA Matrix and AIxMed-powered AI QA stack on technology and target users.
- Proscia: Proscia offers a digital pathology platform (Concentriq) used by pathology labs and biopharma for whole-slide image management, AI integration, and remote collaboration. It is directly comparable to PathNet's digital pathology platform and LIS workflow on product and customer base, though it is software-only rather than a lab.
Regional players
- ARUP Laboratories: ARUP is a large academic/clinical reference laboratory affiliated with the University of Utah, providing specialty and anatomic pathology services. Comparable to PathNet on specialty testing depth and CLIA-grade lab services, but with a distinct regional/academic orientation rather than a national independent-practice focus.
Broad incumbents
- NeoGenomics: NeoGenomics is a specialty oncology diagnostics laboratory serving hospitals, oncologists, and pathologists with molecular and surgical pathology services. Comparable to PathNet on specialty oncology lab focus, though at meaningfully larger scale and with broader oncology/precision medicine scope.
- Quest Diagnostics: Quest Diagnostics is one of the largest reference laboratory networks in the US, providing clinical and anatomic pathology nationwide with multi-state CLIA infrastructure. Comparable as a national lab competitor PathNet would compete against on routine pathology send-outs.
- Tempus AI: Tempus is an AI-driven precision medicine company offering genomics, pathology, and data services including the Tempus Edge platform, which PathNet integrates with. Comparable as a digital pathology AI partner and as a broader force in computational pathology, though at larger scale.
- Labcorp Diagnostics: Labcorp operates one of the largest US clinical and anatomic pathology reference lab networks. Comparable on national lab scale, multi-state operations, and broad physician/clinic outreach that competes with PathNet for specialty biopsy volume.
Emerging players
- AIRA Matrix: AIRA Matrix develops AI Prostate Suite and other computational pathology algorithms deployed in prostate cancer grading workflows. Comparable as a direct AI technology partner to PathNet and as an emerging AI pathology vendor serving a similar pathologist customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
PathNet social profiles
Digital presencePathNet compliance and trust
Trust signalCompliance6 records
PathNet financial estimates
Financial estimateRevenue estimate
Valuation estimate
PathNet leadership team
Management profileNumber of profiles
Profiles10 records
PathNet subsidiaries and ownership
Company hierarchySubsidiaries1 record
PathNet funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PathNet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PathNet
What does PathNet do?
PathNet operates a national digital pathology laboratory network that delivers whole-slide digital imaging, cloud-based remote case sign-out, AI-integrated quality assurance, tissue processing using proprietary BxBoard/BxChip collection devices, and administrative business support services. The company processes specimens shipped from urology, dermatology, and gastroenterology practices and returns diagnostic results within 24-48 hours across 27 US states.
Is PathNet a public or private company?
PathNet is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PathNet founded?
PathNet was founded in 2019. It employs 51 to 100 people.
Where is PathNet based?
PathNet is headquartered in Little Rock, United States, in the North America region.
How does PathNet make money?
Three revenue lines are on record. Laboratory Diagnostic Services are the primary driver. The others are digital Pathology Platform Access and business Support Services.
Who are PathNet's main competitors?
Direct peers on record are Inform Diagnostics, PathAI, Ibex Medical Analytics and Proscia. ARUP Laboratories is listed as a regional player. Broad incumbents are NeoGenomics, Quest Diagnostics, Tempus AI and Labcorp Diagnostics. AIRA Matrix is listed as an emerging player.
Does PathNet have an API?
No public API is recorded for PathNet.
What industry is PathNet in?
PathNet's product category is Digital Pathology Laboratory Services. Its primary akta.pro industry code is HLACAMAJ, Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces, with a secondary code of HLACALAI, Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web). Its NAICS code is 6215 and its SIC code is 8071.